In addition, one study found that postmenopausal women with T2D were more likely to have upregulated CCL20 expression levels, which might be closely related to a more pronounced liver inflammatory response and susceptibility to NASH in these patients (25). This evidence concerns the gene CCL20 and metabolic dysfunction-associated steatohepatitis.